Van de Water T R, Galinovic-Schwartz V
Dept. of Otolaryngology, Albert Einstein College of Medicine, Bronx, NY 10461.
Hear Res. 1987;30(1):39-47. doi: 10.1016/0378-5955(87)90181-x.
Immunocytochemistry was used to demonstrate type II collagen distribution during normal development of the mouse inner ear and in two malformed inner ears. Patterns of inner ear abnormalities and type II collagen distribution were compared between the malformed labyrinth of a mouse mutation (disproportionate micromelia, Dmm) and otic explants exposed to the teratogenic action of an L-proline analog, L-azetidine-2-carboxylic acid (LACA). The results suggest that type II collagen is an important constituent of the developing inner ear's extracellular matrix. Disruptions of the spatial and temporal pattern of collagen type II can adversely affect morphogenesis of the inner ear. A common mechanism of action is postulated for the causation of both the genetic and teratogen-induced inner ear malformations (i.e. disruption of the secretion of collagens to the otic extracellular matrix).
免疫细胞化学法用于显示小鼠内耳正常发育过程中以及两个畸形内耳中II型胶原蛋白的分布。比较了小鼠突变(不成比例的短肢畸形,Dmm)的畸形迷路与暴露于L-脯氨酸类似物L-氮杂环丁烷-2-羧酸(LACA)致畸作用的耳外植体之间的内耳异常模式和II型胶原蛋白分布。结果表明,II型胶原蛋白是发育中的内耳细胞外基质的重要组成部分。II型胶原蛋白时空模式的破坏会对内耳形态发生产生不利影响。推测遗传和致畸剂诱导的内耳畸形的病因有一个共同的作用机制(即胶原蛋白向耳细胞外基质的分泌受到破坏)。